The emerging treatment of the medication represents a significant breakthrough in the care of the condition. Unlike existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – providing https://tirzepatidepeptide066751.wssblogs.com/41903514/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment